Markowski Investments’s Gilead Sciences GILD Stock Holding History

Markowski Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$100K	Buy	+792	New	+$104K	0.02%	160

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Markowski Investments's GILD Position: Q2 2026 in Review

Markowski Investments opened a new position in Gilead Sciences (GILD) in Q2 2026: 792 shares worth $100K. The stake represents 0.02% of the portfolio and ranks #160 among its holdings.

1,917 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Markowski Investments held 792 shares of Gilead Sciences worth $100K as of Q2 2026.
Gilead Sciences was a new Markowski Investments position in Q2 2026.
Gilead Sciences made up 0.02% of Markowski Investments's portfolio in Q2 2026, its #160 holding.
1,917 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.